Jack Abraham - Dec 14, 2021 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role: 10%+ Owner
Signature: /s/ Jack Abraham
Stock symbol: HIMS
Transactions as of: Dec 14, 2021
Transactions value $: -$5,548,300
Form type: 4
Date filed: 12/16/2021, 08:23 PM
Previous filing: Aug 6, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HIMS	Class A Common Stock	Sale	-$5.55M	-1M	-12.24%	$5.55	7.17M	Dec 14, 2021	See Footnote	F1, F2, F3
holding	HIMS	Class A Common Stock						719K	Dec 14, 2021	Direct
holding	HIMS	Class A Common Stock						253K	Dec 14, 2021	See Footnote	F4
holding	HIMS	Class A Common Stock						869K	Dec 14, 2021	See Footnote	F5
holding	HIMS	Class A Common Stock						650K	Dec 14, 2021	See Footnote	F6
holding	HIMS	Class A Common Stock						5.52M	Dec 14, 2021	See Footnote	F7
holding	HIMS	Class A Common Stock						4.38M	Dec 14, 2021	See Footnote	F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities reported herein as indirectly owned by the Reporting Person are held directly and indirectly by the entities referred to in footnotes (3) through (7) below (collectively, the "Controlled Entities"). The Reporting Person disclaims beneficial ownership of the securities held by the Controlled Entities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting Person is the beneficial owner of such securities for any other purpose. The Reporting Person disclaims the existence of a "group" with or among any of the Controlled Entities.
F2	Weighted average price, as these shares were sold in multiple transactions at prices ranging from $5.47 to $5.765, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	Securities are owned by F41 Investments LLC ("F41"). The Reporting Person is the managing member of F41 and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by F41.
F4	Securities are owned by Atomic Incentives, LLC ("Incentives") and Atomic Labs, LLC ("Labs"). Labs is the sole member of Incentives. The Reporting Person is the sole manager of Labs and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Incentives and Labs. Since the date of the last Form 4 filed by the Reporting Person, Incentives distributed 26,571 shares of Class A Common Stock to its profits interest holders, resulting in a reduction in the number of shares reported herein as owned by Incentives.
F5	Securities are owned by Atomic Labs I, L.P. ("Labs I"). Atomic Labs GP I, LLC ("Labs GP I") is the general partner of Labs I. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owner by Labs I. Since the date of the last Form 4 filed by the Reporting Person, Labs I distributed 434,640 shares of Class A Common Stock to its limited partners, resulting in a reduction in the number of shares reported herein as owned by Labs I.
F6	Securities are owned by Atomic Labs I-B, L.P. ("Labs I-B"). Labs GP I is the general partner of Labs I-B. The Reporting Person is the sole managing member of Labs GP I and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs I-B. Since the date of the last Form 4 filed by the Reporting Person, Labs I-B distributed 324,888 shares of Class A Common Stock to its limited partners, resulting in a reduction in the number of shares reported herein as owned by Labs I-B.
F7	Securities are owned by Atomic Labs II, L.P. ("Labs II"). Atomic Labs GP II, LLC ("Labs GP II") is the general partner of Labs II. The Reporting Person is a managing member of Labs GP II and, as such, may be deemed to hold voting and dispositive power with respect to the securities owned by Labs II. Since the date of the last Form 4 filed by the Reporting Person, Labs II distributed 2,760,303 shares of Class A Common Stock to its limited partners, resulting in a reduction in the number of shares reported herein as owned by Labs II.
F8	Securities are held by The Jack Abraham 2020 Irrevocable Trust A, which is a trust the holdings of which may be attributable to the Reporting Person.